Weiss Multi-Strategy Advisers’s Epizyme, Inc EPZM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$50K	–	832
2021 Q4	$50K	Sell	20,000 -4,037	-17%	-$15.9K	﹤0.01%	632
2021 Q3	$123K	Sell	24,037 -2,124	-8%	-$12.9K	﹤0.01%	651
2021 Q2	$217K	Buy	26,161 +934	+4%	+$7.87K	﹤0.01%	616
2021 Q1	$220K	Sell	25,227 -307	-1%	-$3.18K	﹤0.01%	642
2020 Q4	$277K	Sell	25,534 -1,770	-6%	-$21.8K	0.01%	624
2020 Q3	$326K	Buy	27,304 +4,579	+20%	+$61.3K	0.01%	510
2020 Q2	$365K	Sell	22,725 -2,352	-9%	-$41.1K	0.01%	487
2020 Q1	$389K	Sell	25,077 -4,923	-16%	-$106K	0.02%	359
2019 Q4	$738K	Sell	30,000 -35,000	-54%	-$520K	0.01%	513
2019 Q3	$670K	Hold	65,000	–	–	0.01%	472
2019 Q2	$816K	Sell	65,000 -10,000	-13%	-$129K	0.02%	391
2019 Q1	$929K	Sell	75,000 -10,000	-12%	-$112K	0.02%	403
2018 Q4	$524K	Buy	85,000 +45,000	+113%	+$344K	0.02%	345
2018 Q3	$424K	Buy	40,000 +12,659	+46%	+$145K	0.01%	455
2018 Q2	$370K	Buy	27,341 +12,341	+82%	+$192K	0.01%	502
2018 Q1	$266K	Buy	+15,000	New	+$253K	0.01%	492

Other funds holding EPZM

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EPZM Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 20,000 shares — an estimated $50K sold.

Weiss Multi-Strategy Advisers first reported a position in EPZM in Q1 2018 and held it in 16 quarters. The position peaked at $929K in Q1 2019. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 Epizyme, Inc shares in Q1 2022, an estimated $50K.
Weiss Multi-Strategy Advisers first reported a position in Epizyme, Inc in Q1 2018 and held it in 16 quarters.
Weiss Multi-Strategy Advisers's Epizyme, Inc position peaked at $929K in Q1 2019.
120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.